4
Changes in Ownership
Altimmune, Inc. Filed Acc 0001104659-22-076291
Chief Scientific Officer sold 5,462 shares at $12.00 ($65,546)
- Chief Scientific Officer acquired 5,462 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Roberts M Scot · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-06-29 | Exercise or conversion : show line 1 in the form | +5,462 | $2.60 | $14,201 | 23,162 | D |
| 2022-06-29 | Sale : show line 2 in the form | −5,462 | $12.00 | $65,546 | 17,700 | D |
| Open-market sales · 5,462 sh · avg $12.00 · $65,546 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-06-29 | Exercise or conversion : show line 3 in the form Stock Options (option to buy) | −5,462 | 12,769 | D |
Loading xslF345X03/tm2220183-1_4seq1.xml…